Many of today’s new pharmaceutical products are actually proteins produced through some living organism. Some of these organisms include mammalian cells, yeast and e-coli bacteria.The production technology around each of these systems require development of expensive and complex bioreactors. Plant made pharmaceuticals, or PMPs, are proteins that are expressed and purified from plants where the plant itself is designed to become the bioreactor. In other words the plant is trained to produce a protein and the time, risk and huge capital expense of a typical bioreactor is avoided.  In addition to this potential cost savings, PMP’s offer a rapidly scalable platform that eliminates many of the concerns surrounding utilization of animal based components.